Valuation Kobayashi Pharmaceutical Co., Ltd. Boerse Muenchen
Stocks
KOY
JP3301100008
Personal Products
|
Real-time
Boerse Muenchen
20:13:04 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 32.00 EUR | 0.00% |
|
0.00% | +11.89% |
Company Valuation: Kobayashi Pharmaceutical Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 704,427 | 650,295 | 503,841 | 463,131 | 403,511 | 435,624 | - | - |
| Change | - | -7.68% | -22.52% | -8.08% | -12.87% | 7.96% | - | - |
| Enterprise Value (EV) 1 | 596,011 | 546,554 | 424,992 | 398,232 | 333,575 | 373,212 | 365,600 | 359,828 |
| Change | - | -8.3% | -22.24% | -6.3% | -16.24% | 11.88% | -2.04% | -1.58% |
| P/E | 35.8x | 34.8x | 25.3x | 46x | 110x | 42.1x | 32.4x | 26.2x |
| PBR | 3.59x | 3.47x | 2.47x | 2.18x | 1.92x | 2.08x | 2.02x | 1.95x |
| PEG | - | 12.08x | 7.7x | -0.9x | -1.7x | 0x | 1.1x | 1.1x |
| Capitalization / Revenue | 4.54x | 3.91x | 2.9x | 2.8x | 2.43x | 2.53x | 2.43x | 2.34x |
| EV / Revenue | 3.84x | 3.29x | 2.45x | 2.4x | 2.01x | 2.17x | 2.04x | 1.93x |
| EV / EBITDA | 19.3x | 17.1x | 13.3x | 12.1x | 14.1x | 17x | 13.6x | 11.6x |
| EV / EBIT | 22.9x | 20.5x | 16.5x | 16x | 22.4x | 29.2x | 21.1x | 16.9x |
| EV / FCF | 31.8x | 31.1x | -350x | -29.2x | 68.5x | 25.9x | 24x | 21x |
| FCF Yield | 3.15% | 3.22% | -0.29% | -3.42% | 1.46% | 3.85% | 4.16% | 4.76% |
| Dividend per Share 2 | 83 | 90 | 101 | 102 | 104 | 106 | 109.5 | 114.3 |
| Rate of return | 0.92% | 1% | 1.49% | 1.64% | 1.92% | 1.81% | 1.87% | 1.95% |
| EPS 2 | 252.4 | 259.6 | 268.2 | 135.4 | 49.19 | 139.1 | 181.1 | 223.7 |
| Distribution rate | 32.9% | 34.7% | 37.7% | 75.3% | 211% | 76.2% | 60.5% | 51.1% |
| Net sales 1 | 155,252 | 166,258 | 173,455 | 165,600 | 165,742 | 172,061 | 179,446 | 186,503 |
| EBITDA 1 | 30,900 | 32,027 | 31,837 | 32,800 | 23,600 | 22,012 | 26,890 | 31,112 |
| EBIT 1 | 26,065 | 26,669 | 25,780 | 24,860 | 14,923 | 12,780 | 17,350 | 21,293 |
| Net income 1 | 19,715 | 20,022 | 20,338 | 10,067 | 3,656 | 10,438 | 13,554 | 16,348 |
| Net Debt 1 | -108,416 | -103,741 | -78,849 | -64,899 | -69,936 | -62,413 | -70,024 | -75,796 |
| Reference price 2 | 9,040.00 | 9,030.00 | 6,790.00 | 6,230.00 | 5,428.00 | 5,860.00 | 5,860.00 | 5,860.00 |
| Nbr of stocks (in thousands) | 77,923 | 72,015 | 74,203 | 74,339 | 74,339 | 74,339 | - | - |
| Announcement Date | 2/4/22 A | 2/14/23 A | 2/9/24 A | 2/10/25 A | 2/10/26 A | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 21.68x | 4.14x | 15.14x | 2.98% | 343B | ||
| 18.21x | 2.71x | 11.94x | 3.55% | 133B | ||
| 23.86x | 3.58x | 15.05x | 2.42% | 69.94B | ||
| 40.38x | 6.48x | 28.13x | 2.31% | 47.65B | ||
| 31.66x | 2.51x | 13.91x | 1.7% | 33.96B | ||
| 18.82x | 2.66x | 11.08x | 4.72% | 34.32B | ||
| 22.57x | 1.65x | 10.53x | 2.24% | 20.28B | ||
| 19.79x | 1.26x | 8.23x | 1.33% | 18.79B | ||
| 15.32x | 1.48x | 8.33x | 3.47% | 18.24B | ||
| Average | 23.59x | 2.94x | 13.59x | 2.75% | 79.9B | |
| Weighted average by Cap. | 22.64x | 3.61x | 14.66x | 2.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 4967 Stock
- KOY Stock
- Valuation Kobayashi Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















